# β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults

> **NCT04953936** · NA · UNKNOWN · sponsor: **West China Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** HMB-enriched Nutritional Supplements
- **DIETARY_SUPPLEMENT:** Placebo
- **BEHAVIORAL:** Caloric Restrition Diet

## Key facts

- **NCT ID:** NCT04953936
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-20
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04953936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04953936, "β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04953936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*